4Brook S, Lucey JV, Gunn KP. For the ziprasidone IM Study Group. Intramuscular ziprasidone compared with Intramuscular haloperidol in the treatment of acute psychosis[J]. J Clin Psychiat ry,2000,61:933.
7Simpson GM, Glick ID, Weiden PJ, et al. Randomized, cont rolled, double - blind multicenter comparsion of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatient s with schizophrenia or schizoaffectivedisorder [ J ]. Am J Psychiat ry, 2004,161 : 1837.
8Allison DB, Mentore JL, Heo M, et al. An tip sychotic - induced weight gain: a comprehensive research synthesis [J]. Am J Psychiatry, 1999,156 : 1686.
9American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocri - nologists, North American Association for the Study of Obesity: consensus devdopment conference on antip sychotic drugs and obesity and diabetes[ J]. J Clin Psychiatry, 2004,65 : 267.
10Stroup TS, Lieberman JA, Swartz MS, et al. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic[J]. Am J Psychiatry, 2006,163 : 611.
二级参考文献13
1Miceli JJ, Anziano RJ, Robarge L, et al. The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers.Br J Clin Pharmacol 2000;49 Suppl 1:65S-70S
2Lesem MD, Zajecka JM, Swift RH, et al. Intramuscular Ziprasidone 2mg versus 10mg in the short term management of agitated psychotic patients. J Clin Psychiatry 2001;62(1):12-8
3Daniel DG, Potkin SG, Reeves KR, et al. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a doubleblind, randomized trial.Psychopharmacology (Berl) 2001;155(2):128-34
4Brook S,Lucey JV,Gunn KP.Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M.Study Group.J Clin Psychiatry 2000;61(12):933-41
5Potkin SG,Keck PE,Segal S, et al. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.J Clin Psychopharmacol 2005;25(4):301-10
6Keck PE Jr, Reeves KR, Harrigan EP; et al.Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two doubleblind, placebo-controlled, multicenter studies.J Clin Psychopharmacol 2001;21(1):27-35
7Wilner KD, Anziano R J, Johnson AC, et al. The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery. J Clin Ps ychopharmacol 2002;22(2):206-10
8Miceli JJ,Anziano RJ,Robarge L,et al.The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers.Br J Clin Pharmacol,2000,49 Suppl 1:65S-70S.
9Lesem MD,Zajecka JM,Swift RH,et al.Intramuscular ziprasidone,2 mg versus 10 mg,in the short-term management of agitated psychotic patients.J Clin Psychiatry,2001,62:12-18.
10Daniel DG,Potkin SG,Reeves KR,et al.Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis:a double-blind,randomized trial.Psychopharmacology (Berl),2001,155:128-134.
7Broon S. Intramuscular ziprasidone:moving beyond the conventional in the treatment of acute agitation in schizophrenia[J].J Clin Psychiatry,2003,64(Suppl 19):13-18.
8Miceli JJ, Anziano RJ, Robarge L, et al. The effect ofcarbmnazepine on the steadstate phannacokineties of ziprasidone in healthe volunteeres[J].Br J Clin Pharmacol, 2000,49(Suppl 1):65-70.
9Harvey PD, Bowie CR. Ziprasidone:efficacy, tolerability, and emerging data on wideranging effectivness[J].Expert Opin Pharmacother,2005,6(2) :337.
10Neborsky R,J anowsky D,Munson E,et al.Rapid t reatment of acute psychotic symptoms wit h high-and low-dose haloperi2 dol.Behavioral considerations.Arch Gen Psychiatry,1981,38(2):195-199.
